|
|
Volumn 282, Issue 20, 1999, Pages 1961-1963
|
|
COX-1-sparing NSAIDs - Is the enthusiasm justified?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTACID AGENT;
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
MISOPROSTOL;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
PROSTAGLANDIN DERIVATIVE;
ROFECOXIB;
UNCLASSIFIED DRUG;
ANALGESIA;
ANTIINFLAMMATORY ACTIVITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIGESTIVE SYSTEM ULCER;
DRUG ACTIVITY;
DYSPEPSIA;
EDITORIAL;
ENZYME INHIBITION;
GASTROINTESTINAL HEMORRHAGE;
GASTROINTESTINAL TOXICITY;
HUMAN;
MAJOR CLINICAL STUDY;
OSTEOARTHRITIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
ULCER PERFORATION;
|
|
EID: 0033601084
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.282.20.1961 Document Type: Editorial |
|
Times cited : (96)
|
|
References (7)
|
